Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria

INTRODUCTION: The 2017 European Union‐North American Clinical Trials in Alzheimer's Disease Task Force recommended development of clinician‐rated primary outcome measures for Alzheimer's disease (AD) agitation trials, incorporating International Psychogeriatric Association (IPA) criteria....

Descripción completa

Detalles Bibliográficos
Autores principales: De Mauleon, Adelaide, Ismail, Zahinoor, Rosenberg, Paul, Miller, David, Cantet, Christelle, O'Gorman, Cedric, Vellas, Bruno, Lyketsos, Constantine, Soto, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292260/
https://www.ncbi.nlm.nih.gov/pubmed/34132461
http://dx.doi.org/10.1002/alz.12335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292260/
https://www.ncbi.nlm.nih.gov/pubmed/34132461
http://dx.doi.org/10.1002/alz.12335

Ejemplares similares